Background: Early post-hatch growth and immunity were assessed through in ovo supplementation of nutrients: amino acids (AA), trace elements (TE), fatty acids and vitamins (FAV) grouped under humoral immunity (HI) or cell-mediated immunity (CMI) on the 18th day of incubation at the broad end of the egg using a 25 mm needle.
Results: Hatchability in AA groups was better than TE and FAV groups. CMI groups had better hatchability than HI groups. AA and TE groups had higher chick-to-egg weight ratio (P < 0.01) than the FAV group. At 3 weeks of age, a higher body weight (P < 0.01) was recorded in AA for CMI, TE for HI and FAV for HI groups. FAV-injected chicks had a higher bursa weight at hatch, but TE chicks had higher thymus weight at the 3rd week of age. Humoral immune response was not different in in ovo injected chicks compared to control. CMI was higher (P < 0.01) in AA for CMI, TE for CMI and FAV for CMI or HI nutrient-injected chicks.
Conclusions: In ovo injection of AA for CMI and TE for HI may accelerate growth of broiler chickens. In ovo injection of AA, TE or FAV may modulate CMI in chicks.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jsfa.4577 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
What is the most effective antibiotic monotherapy for severe Pseudomonas aeruginosa infection? A systematic review and meta-analysis of randomized controlled trials.
Clin Microbiol Infect
December 2024
Internal Medicine Department, Maayenei Hayeshua Medical Center, Bnei-Brak, Israel; Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Objectives: To compile the evidence of sub-groups of patients with Pseudomonas aeruginosa (P. aeruginosa) infection from randomized control trials (RCTs) evaluating different definite antipseudomonal monotherapies for severe P.aeruginosa infection.
View Article and Find Full Text PDFMore nuance and transparency are needed when setting breakpoints for antimicrobial susceptibility testing of pretomanid.
Clin Microbiol Infect
December 2024
Department of Genetics, University of Cambridge, Cambridge, UK. Electronic address:
Not "a cute" complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia.
Clin Microbiol Infect
December 2024
Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia; School of Medicine and Public Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.
Objectives: In this large retrospective cohort analysis, we aimed to determine the incidence of KDIGO-defined acute kidney injury (AKI) within 14 days in patients with Staphylococcus aureus bacteraemia, and the association of AKI with 30-day mortality.
Methods: A retrospective cohort study of adults with S. aureus bacteraemia between 1998 to 2023 admitted to a large regional Australian health service.
Optical molecular imaging in oral- and oropharyngeal squamous cell carcinoma using a novel uPAR-targeting near-infrared imaging agent FG001 (ICG-Glu-Glu-AE105): An explorative phase II clinical trial.
Theranostics
January 2025
Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging (CMI), Copenhagen University Hospital, Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Denmark.
: In oral and oropharyngeal squamous cell carcinoma (OSCC, OPSCC), frequent inadequate surgical margins highlight the importance of precise intraoperative identification and delineation of cancerous tissue for improving patient outcomes. : A prospective, open-label, single-center, single dose, exploratory phase II clinical trial (EudraCT 2022-001361-12) to assess the efficacy of the novel uPAR-targeting near-infrared imaging agent, FG001, for intraoperative detection of OSCC and OPSCC. Macroscopic tumor detection was quantified with sensitivity and intraoperative tumor-to-background ratio (TBR).
View Article and Find Full Text PDFThe novel EFLM European Urinalysis Guideline: what clinical microbiologists should know.
Clin Microbiol Infect
December 2024
University of Helsinki, Department of Clinical Chemistry, and HUS Diagnostic Center, Hospital District of Helsinki and Uusimaa, 00014 Helsinki, Finland. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!